TVRD(Tvardi Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2020-12-31 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $135.08M | $23.03M | $41.87M | $20.97M | $7.14M |
| 毛利润 | — | $23.03M | — | — | — |
| 营业利润 | $5.38M | −$89.08M | −$87.53M | −$121.50M | −$28.11M |
| 净利润 | $8.41M | −$88.44M | −$85.47M | −$118.51M | −$29.40M |
| 经营现金流 | −$5.49M | −$60.09M | −$78.73M | −$92.08M | −$18.30M |
| 自由现金流 | −$5.84M | −$60.13M | −$78.77M | −$94.45M | −$19.35M |
| 摊薄每股收益 | $6.48 | $-62.64 | $-57.36 | $-78.78 | $-11.42 |